Erythrovirus B19 infection;Infección por Erythrovirus B19

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 24, Issue SUPPL.1, 2006, Pages 24-29

  García Tapia, Ana María ^a   Domínguez, María Del Carmen Lozano ^a   Fernandez Gutierrez Del Alamo, Clotilde ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

Author keywords

Erythema infectiosum; Erythrovirus B19; Parvovirus B19; Pure red cell aplasia

Indexed keywords

IMMUNOGLOBULIN;

ANEMIA; ARTHROPATHY; ARTICLE; BACTERIUM DETECTION; ERYTHEMA; ERYTHEMA INFECTIOSUM; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNE STATUS; IMMUNOCOMPROMISED PATIENT; INTRAUTERINE INFECTION; PARVOVIRUS; PREGNANT WOMAN; SERODIAGNOSIS;

HUMANS; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN;

EID: 34548729071     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1157/13094275     Document Type: Article

References (41)

1. Cossart YE, Field AM, Cant B, Widdows D. Parvovirus-like particles in human sera. Lancet. 1975;1:72-3.
2. Servant A, Laperche S, Lallemand F, Marinho V, De SaintMaur G, Meritet JF, et al. Genetic diversity within human erytrhoviruses: identification of three genotypes. J Virol. 2002;76:9124-34.
3. Nguyen OT, Wong S, Heegaard ED, Brown KE. Identification and characterization of a second novel human erythrovirus variant A6. Virology. 2002;301:374-80.
4. Hokynar K, Söderlund-Venermo M, Pesonen M, Ranki A, Kiviluoto O, Partio EK, et al. A new parvovirus genotype persistent in human skin. Virology. 2002;302:224-48.
5. Pattison JR, Jones SE, Hodgson J, Davis LR, White JM, Stroud CE, et al. Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancet. 1981;1:664-5.
6. Anderson MJ, Higgins PG, Davis LR, Willman JS, Jones SE, Kidd IM, et al. Experimental parvoviral infection in human. J Infect Dis. 1985;152:257-65.
7. Mortimer PP, Cohen BJ, Buckley MM, Cradock-Watson JE, Ridehalgh MK, Burkhardt F, et al. Human parvovirus and the fetus. Lancet. 1985;2:1012.
8. Morey AL, Keeling JW, Porter HJ, Fleming KA. Clinical and histopathological features of parvovirus B19 infection in the human fetus. Br J Obstet Gynaecol. 1992;99:566-74.
9. Reid DM, Brown T, Reid TMS, Rennie JAN, Eastmond CJ. Human parvovirus asociated arthritis: a clinical and laboratory description. Lancet. 1985;1:422-5.
10. Nocton JJ, Miller LC, Tucker LB, Schaller JG. Human Parvovirus B19 associated arthritis in children. J Pediatr. 1993;122:186-90.
11. Kurtzman G, Frickhofen N, Kimball J, Jenkins DW, Nienhuis AW, Young NS. Pure red cell aplasia of 10 years duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N Engl J Med. 1989;321:519-23.
12. Mintzer D, Reilly R. Pure red cell aplasia associated with human immunoceficiency virus infection: response to intravenous gammaglobulin. Blood. 1987;87:124a.
13. Fickhofen N, Abkowitz JL, Safford M, Berry JM, Mayolo J, Astrow A, et al. Persistent parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia with AIDS. Ann Intern Med. 1990;113:926-33.
14. Williams MD, Cohen BJ, Beddall AC, Pasi KJ, Mortimer PP, Hill FGH. Transmission of human parvovirus B19 by coagulation factor concentrates. Vox Sang. 1990; 58:177-81.
15. García-Tapia AM, Fernández-Gutiérrez del Alamo C, Girón JA, Mira J, De la Rubia F, Martínez-Rodríguez, et al. Spectrum of parvovirus B19 infections: analysis of an outbreak of 43 cases in Cádiz, Spain. Clin Infect Dis. 1995;21:1424-30.
16. Saarinen UA, Chorba TL, Tattersall P, Young NS, Anderson LJ, Palmer E, et al. Human parvovirus B19-induced epidemic acute red cell aplasia in patients with hereditary hemolytic anemia. Blood. 1986;67:1411-17.
17. Bell LM, Naides SJ, Stoffman P, Hodinka RL, Plotkin SA. Human parvovirus B19 infection among hospital staff members after contact with infected patients. N Engl J Med. 1989; 321:485-91.
18. Potter CG, Potter AC, Hatton SCR, Chapel HM, Anderson MJ, Pattison JR, et al. Variation of erythroid and myeloid precursors in the marrow and peripheral blood of volunteer subjects infected with human parvovirus (B19). J Clin Invest. 1987;79:1486-92.
19. Corcoran A, Doyle S. Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19. J Med Microbiol. 2004;53:459-75.
20. Lehmann HW, Knöll A, Küster RM, Modrow S. Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood. Arthritis Rheum. 2003;48:1631-38.
21. Naides SJ, Schazosch LL, Foto F, Howard EJ. Rheumatologic manifestations of human parvovirus B19 infection in aduts. Arthritis Rheum. 1990;33:1297-309.
22. Nunoue T, Kusuhara K, Hara T. Human fetal infection with parvovirus B19: maternal infection time in gestation, viral persistence and fetal prognosis. Pediatr Infect Dis J. 2002;21:1133-6.
23. Pride PG, Nugent CE, Pridjian G, Barr M, Faix RG. Spontaneous resolution of nonimmune hydrops fetalis secondary to human parvovirus B19 infection. Obstet Gynecol. 1992;79:859-61.
24. Martín MV, García-Tapia AM, Fernández C, Muñoz JA. Aplasia eritroide en anemia diseritropoyética congénita inducida por parvovirus B19. Sangre. 1993;38:416-7.
25. García-Tapia AM, Fernández C, Martín MV, Muñoz JA. Infección por parvovirus humano B19 en enfermos con anemia hemolítica hereditaria. VI Reunión de la Sociedad Andaluza de Microbiología y Parasitología Clínica. Jaén, 29-30 de octubre, 1993. Libro de resúmenes 1993; 126.
26. García-Tapia AM, Fernández C, Bascuñana A. Infección persistente por parvovirus B19 en una paciente con sida. Enferm Infecc Microbiol Clin. 1993;11:107-8.
27. García-Tapia AM, Martínez A, Fernández C, Mira J, Lechuga JL. Eritema multiforme ampolloso por parvovirus humano B19. Enferm Infecc Microbiol Clin 1993;11:575-6.
28. Yoto Y, Kudoh T, Haseyama K, Suzuki N, Chiba S. Human parvovirus B19 infection associated with acute hepatitis. Lancet. 1996;347:868-9.
29. Chia JK, Jackson B. Myopericarditis due to parvovirus B 19 in an adult. Clin Infect Dis. 1996;23:200-1.
30. Magro CM, Dawood MR, Crowson AN. The cutaneous manifestations of human parvovirus B19 infection. Hum Pathol. 2000; 31:488-97.
31. Wattre P, Dewilde D, Subtil D, Andreoletti L, Thirion V. A clinical and epidemiology study of human parvovirus B19 infection in fetal hydrops using PCR Southern blot hibridization and chimiluminiscence detection. J Med Virol. 1998;54:140-4.
32. Kerr S, O'Keeffe G, Kilty C, Doyle S. Undenatured parvovirus B19 antigens are essential for the accurate detection of parvovirus B19 IgG. J Med Virol. 1999;57:179-85.
33. Corcoran A, Doyle S. Evidence of serological cross-reactivity between genotype 1 and genotype 3 erythrovirus infections. J Virol. 2005; 79:5238-9.
34. Doyle S, Kerr S, O'Keeffe G, O'Carroll D, Dayly P, Kilty C. Detection of parvovirus B19 IgM by antibody capture enzyme immunoassay: receiver operating characteristic analysis. J Virol Methods. 2000; 90:143-52.
35. Heegaard ED, Petersen B, Heilmann CJ, Hornsleth A. Prevalence of parvovirus B19 and parvovirus V9 DNA and antibodies in paired bone marrow and serum samples from healthy individuals. J Clin Microbiol. 2002;40:933-6.
36. Mosquera MM, De Ory F, Moreno M, Echevarría JE. Simultaneous detection of measles virus, rubella virus, and parvovirus B19 by using multiplex PCR. J Clin Microbiol. 2002;40:111-6.
37. Aberham C, Pendl C, Gross P, Zerlauth G, Gessner M. A quantitative, internally controlled real-time PCR assay for the detection of parvovirus B19 DNA. J Virol Methods. 2001;92:183-91.
38. Harder TC, Hufnagel M, Zahn K, Beutel K, Schmitt HJ, Ullmann U, et al. New LightCycler PCR for rapid and sensitive quantification of parvovirus B19 DNA guides therapeutic decision-making in relapsing infections. J Clin Microbiol. 2001;39:4413-9.
39. Hokynar K, Norja P, Laitinen H, Palomäki P, Garbarg-chenon A, Ranki A, et al. Detection and differentiation of human parvovirus variants by commercial quantitative real-time PCR tests. J Clin Microbiol. 2004;42:2013-9.
40. Ballou WR, Reed JL, Noble W, Young NS, Koening S. Safety and immunogenicity of a recombinant parvovirus B19 vaccine formulated with MF59C.1. J Infect Dis. 2003;187:675-8.
41. Selbing A, Josefsson A, Dahle LO, Lindgren R. Parvovirus B19 infection during pregnancy treated with high-dose intravenous gammaglobulin. Lancet. 1995;345:660-1.